Intracranial complete response to toripalimab and anlotinib in a patient with recurrent brain metastases of small cell lung cancer after failure of second-line maintenance therapy: a case report

BACKGROUND: Approximately 10–25% of patients with small cell lung cancer (SCLC) have brain metastases at the time of diagnosis. Radiotherapy is a common treatment for brain metastases, but the relapse rates are high. Accumulating evidence suggests that immunotherapy may have a better therapeutic eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Fengxiang, Tang, Jiaqi, Lou, Jiaojiao, Wang, Qilong, Ma, Kai, Qiao, Ruiping, Si, Jiming, Kang, Yan, Chen, Hongjie, Mei, Jingjing, Wang, Huanqin, Liu, Yuanhua, Miao, Lijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552078/
https://www.ncbi.nlm.nih.gov/pubmed/36237231
http://dx.doi.org/10.21037/tcr-22-666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552078/
https://www.ncbi.nlm.nih.gov/pubmed/36237231
http://dx.doi.org/10.21037/tcr-22-666

Ejemplares similares